Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292352 · ClinicalTrials.gov registry record · NA
Prevention of NAFLD in Hispanic Children
A NA study of Non-alcoholic Fatty Liver Disease, sponsored by Emory University.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT05292352: Active NA study of Non-alcoholic Fatty Liver Disease, sponsored by Emory University.
NCT05292352 is a NA study of Non-alcoholic Fatty Liver Disease that is active but no longer recruiting, run by Emory University. The registered enrollment target is 103 participants, below the 175-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05292352, a NA study of Non-alcoholic Fatty Liver Disease, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
Primary Outcome
The primary objective for the 12-month study is to test if an LFSD, compared to usual diet protects against increase in hepatic steatosis
Conditions Studied
Interventions
- BEHAVIORAL LFSD
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What the registry record for NCT05292352 still lists
NCT05292352 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 175-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which LFSD is the first listed.
NCT05292352 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05292352 about?
NCT05292352 is a clinical study titled "Prevention of NAFLD in Hispanic Children". This is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
What is the current status of trial NCT05292352?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2022-04-06. Estimated completion is 2027-03-31.
What conditions does trial NCT05292352 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT05292352?
The interventions under investigation include: LFSD (BEHAVIORAL).
Who is sponsoring clinical trial NCT05292352?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292352 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05292352's enrollment target sits among peer trials
103 19th of 57 higher than 39 of 57 other Non-alcoholic Fatty Liver Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI